The γmean, γmedian and γ1% metrics have potential to be used as parameters to predict PTV dose deviations and had better correlation than the passing rate. However for OAR dose deviations, the γmax showed the strongest correlation with DVH deviations. This methodology is robust the variability in γ calculation.
Purpose or Objective:
Aim of this study is the evaluation of build-up and superficial doses for a Head&Neck treatment, delivered by Helical TomoTherapy (HT). Measurements were carried out by two different dosimeters (radiochromic films and a synthetic single crystal diamond detector) and compared with TPS data. Build-up dose profiles and superficial dose points were estimated. The reliability of the TPS in these critical regions was assessed, giving an insight into a subject on which quite contradictory results are reported in the literature.
Material and Methods:
A home modified Anderson Rando phantom was employed to house the detectors. As shown in figure (a), two slices of the phantom neck were removed and replaced with a PMMA artificial neck, with a hole inside to mimic the trachea. This allowed to measure dose profiles and superficial dose points with geometrical and scattering conditions similar to the ones taking place when a real patient is treated. Gafchromic EBT3 films (Ashland Inc., Wayne, NJ) were sandwiched inside the neck in oder to measure dose profiles and attached to the neck surface for superficial dose point assessment. PTW-Frieburg microDiamond (mD) was positioned inside drilled holes at different known distances respect to the phantom surface.
Results:
In figure (b) one of the measured dose profiles by EBT3 and mD is reported, along the Antero-Posterior direction, in the range 0-30 mm (distance from the phantom surface). TPS data are also shown, as black dots, with an associated error of ± 0.9 mm, half of the lateral dimension of the calculation pixel (fine grid). The prescribed dose is reached within approximately 4 mm from the phantom surface and it does not show any significant variation going further inside the neck, in particular at the PMMA/air interface, in correspondence of the trachea starting point. A 1D threshold criterion of 3%/mm was adopted in order to discriminate between high and low gradient zones. Dose differences (DD) measured by mD are within 2.5% respect to TPS, in the low gradient region, while a maximum distanceto-agreement (DTA) of 0.9 mm is found for the same device, in the high gradient region. EBT3 profile shows a more noisy behavior, with a maximum DD of 3.8% in the low gradient portion of the profile, while DTA is less than 1 mm in the high gradient zone. The superficial dose measurement by EBT3 film is characterized by a DTA of 0.5 mm and a DD of 5.2%.
Conclusion:
Build-up dose profiles measured by the two dosimeters show the same behavior and are in agreement with TPS data; deviations are well within the reference tolerance level. The investigation carried out in this work offers the possibility of studying the TPS behavior not only in terms of dose difference, as carried out for in vivo measurements, but also taking into account a "spatial displacement", to be compared with patient (and/or dosimeter) positioning uncertainties. 
EP-1590 Verification of small-field VMAT plans using a 2D detector array in a rotational phantom

Material and Methods:
The Octavius 1000SRS detector array inserted in the rotational Octavius4D phantom (PTW) was used, consisting of 977 liquid-filled ion chambers covering an area of 11×11cm2. The detector size (2.3×2.3×0.5mm3) and the center-to-center distance of the detectors (2.5mm in the inner 5.5×5.5cm2 area) are important parameters for correct spatial measurement of complex dose distributions with steep dose gradients. Clinical treatment plans (n = 28), characterized by small treatment volumes, 6 and 10MV photon beams, and fraction doses between 2.75-30 Gy, were projected on the phantom CT data set and recalculated in the Eclipse TPS v11 (Varian Medical Systems) using AcurosXB with a calculation grid size of 2.5mm and 1mm (field sizes <3x3cm2). All measurements were done on a Varian TrueBeamSTx linac. The irradiation technique used was ________________________________________________________________________________ VMAT, but in a few cases also dynamic conformal arc for the smallest treatment field sizes. The effect of disabling jaw tracking, thereby fixating the collimator jaws at 3x3cm2 and applying the MLC to shape the smallest apertures was investigated for static fields between 3x3cm2 and 0.5x0.5cm2, and for 7 stereotactic patients with small brain metastases. To evaluate the dosimetric agreement between measured and calculated dose, a local gamma evaluation criterion of 2%/2mm was used.
Results:
Regarding the clinical VMAT plans, the mean and SD of the volumetric gamma evaluation scores with 10%, 50%, 80% and 95% cut-off dose values are (96±6.9)%, (95.2±6.8)%, (86.7±14.8)% and (56.3±42.3)% respectively. In figure 1, a trend can be observed between relative dose differences and the field size area of 28 VMAT treatments going from very small to medium sized fields. The deviation between 1000SRS readings for static fields 3x3, 2x2, 1x1 and 0.5x0.5cm2 collimated with MLC and jaws fixed at 3x3cm2 and with collimator jaws only is on average respectively, 0.3%, 0.8%,6.7%, 5.4% (6 MV) and 0.2%,1.3%,11.3%,20.1% (10MV). The effect of disabling jaw tracking for 7 stereotactic patients with treatment techniques VMAT as well as dynamic conformal arc is shown in table 1: the smaller the target, the higher the improvement in agreement between measured and calculated doses when jaws are fixed at 3x3cm2 .
Conclusion: Doses calculated for stereotactic VMAT plans
show an acceptable agreement against measurements with the 1000SRS in the Octavius4D system. Except for very small highly modulated VMAT fields, larger discrepancies are obtained. Fixating the jaws at 3x3cm2 and using the MLC with high positional accuracy to shape the smallest apertures in contrast to jaw tracking is currently found to be the preferred and most accurate treatment technique.
EP-1591
Investigation on backscattered dose of absorber plates for IORT application M.N. Pirpir Purpose or Objective: In intraoperative electron radiation therapy (IOERT) a high single dose is applied to the tumor bed directly after resection of the malignancy. During an IOERT clinical application special shielding materials are used under the tumor bed in order to reduce the absorbed dose on critical organs behind the tumor like rib, heart and lung. Such absorbers produce backscattered dose. The objective of the present study was to investigate the backscattered dose of the absorber shielding plates. This could help us to comprehend the effect of the clinical application of such absorbers.
Material and Methods:
The electron beams generated by a dedicated mobile IOERT accelerator NOVAC7 (SIT, Vicenza/Italy) were employed. The electron beams with different energies of 5 and 9 MeV together with 40 and 50 mm applicators which are most clinically used were utilised. These shielding plates are made up of a special steel alloy (AISI 316L). The backscattered dose was measured by radiochromic films, Gafchromic EBT3 (Ashland, Wayne/USA). All films were irradiated with 5 Gy at 100% isodose level.
Results: Some important aspects of results are explained below. 40mm applicator: At the first film slice, increasing the energy from 5 to 9 MeV resulted to a significantly higher backscattered dose. At 5 MeV the backscattered dose was 0.29 Gy, compared to the dose resulted for the film slice without the shielding. The corresponding values were 0.63 Gy for 9 MeV. This increase might be because of the increased energy of the backscattered electrons at higher energy beams (9 MeV) which causes higher dose delivery at the same depth, compared to low energy beams (5 MeV). Moving toward the surface of the phantom the backscattered dose decreased significantly (~11%). This occurs due to decrease of energy and fluence of backscattered electrons when they move toward the phantom surface. 50mm applicator: At larger field size of 50 mm, the backscattered dose increased remarkably, compared to the 40 mm applicator. In comparison with the dose absorbed to the film slice without the shielding, the backscattered dose increased 1.5 and 1.3 Gy for 5 and 9 MeV, respectively. The reason is that at larger field size the energy fluence of scattered electrons might be higher than the 40 mm applicator and this led to a higher dose delivery at the same depth, compared to 40 mm field size.
